AXGN RSI Chart
Last 7 days
5.0%
Last 30 days
-13.0%
Last 90 days
-43.0%
Trailing 12 Months
-34.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 163.7M | 0 | 0 | 0 |
2023 | 144.2M | 147.9M | 152.3M | 159.0M |
2022 | 127.3M | 128.2M | 134.0M | 138.6M |
2021 | 119.1M | 130.5M | 128.3M | 127.4M |
2020 | 107.7M | 103.1M | 108.0M | 112.3M |
2019 | 90.0M | 96.1M | 102.0M | 106.7M |
2018 | 65.4M | 70.9M | 77.5M | 83.9M |
2017 | 45.2M | 50.0M | 54.9M | 60.4M |
2016 | 30.5M | 34.5M | 37.5M | 41.1M |
2015 | 18.6M | 20.8M | 24.3M | 27.3M |
2014 | 11.9M | 13.3M | 15.0M | 16.8M |
2013 | 8.2M | 9.0M | 10.0M | 10.9M |
2012 | 5.4M | 6.2M | 7.0M | 7.7M |
2011 | 3.5M | 3.9M | 4.4M | 4.8M |
2010 | 0 | 0 | 0 | 3.0M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 21, 2024 | scopelianos angelo | acquired | - | - | 2,500 | chief r&d officer |
Mar 21, 2024 | donovan michael patrick | sold | -46,333 | 7.68 | -6,033 | vp operations |
Mar 21, 2024 | devinney erick wayne | sold | -35,159 | 7.68 | -4,578 | chief innovation officer |
Mar 21, 2024 | zaderej karen l. | sold | -301,670 | 7.68 | -39,280 | ceo |
Mar 21, 2024 | scopelianos angelo | sold | -52,846 | 7.68 | -6,881 | chief r&d officer |
Mar 16, 2024 | devinney erick wayne | acquired | - | - | 18,675 | chief innovation officer |
Mar 16, 2024 | donovan michael patrick | acquired | - | - | 24,575 | vp operations |
Mar 16, 2024 | zaderej karen l. | acquired | - | - | 110,322 | ceo |
Mar 16, 2024 | scopelianos angelo | acquired | - | - | 25,406 | chief r&d officer |
Mar 07, 2024 | donovan michael patrick | sold | -319,891 | 8.81 | -36,310 | vp operations |
Which funds bought or sold AXGN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -38.29 | -12,384 | 33,329 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -75.69 | -368,181 | 148,399 | -% |
May 15, 2024 | PERCEPTIVE ADVISORS LLC | added | 92.23 | 7,018,970 | 12,540,200 | 0.22% |
May 15, 2024 | MAIRS & POWER INC | unchanged | - | 21,080 | 137,190 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -10.21 | 216,957 | 3,780,270 | -% |
May 15, 2024 | DAFNA Capital Management LLC | unchanged | - | 1,160,510 | 7,552,660 | 1.72% |
May 15, 2024 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | reduced | -67.00 | -222,000 | 141,000 | -% |
May 15, 2024 | UNITED CAPITAL FINANCIAL ADVISORS, LLC | reduced | -0.6 | 26,375 | 177,564 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | new | - | 82,814 | 82,814 | -% |
May 15, 2024 | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | unchanged | - | 170,593 | 1,110,230 | 0.08% |
Unveiling AxoGen Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to AxoGen Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.1B | 40.3B | 32.19 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.23 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.21 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.78 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.28 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.62 | 0.77 | ||||
BIO | 8.4B | 2.6B | -25.99 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.8 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 55.4M | 50.5M | -2.43 | 1.1 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
AxoGen Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -3.6% | 41,378,000 | 42,922,000 | 41,271,000 | 38,155,000 | 36,664,000 | 36,164,000 | 36,959,000 | 34,454,000 | 31,007,000 | 31,537,000 | 31,204,000 | 33,580,000 | 31,037,000 | 32,495,000 | 33,428,000 | 22,116,000 | 24,261,000 | 28,162,000 | 28,564,000 | 26,701,000 | 23,285,000 |
Gross Profit | -3.4% | 32,620,000 | 33,764,000 | 33,228,000 | 30,927,000 | 29,955,000 | 30,023,000 | 30,783,000 | 28,170,000 | 25,461,000 | 26,109,000 | 25,965,000 | 26,488,000 | 25,865,000 | 27,032,000 | 27,731,000 | 16,511,000 | 19,445,000 | 23,281,000 | 24,054,000 | 22,457,000 | 19,571,000 |
Costs and Expenses | 0.6% | 37,180,000 | 36,958,000 | 37,253,000 | 37,829,000 | 37,296,000 | 35,631,000 | 35,638,000 | 36,094,000 | 36,781,000 | 31,462,000 | 32,654,000 | 33,642,000 | 32,085,000 | 32,406,000 | 28,776,000 | 24,765,000 | 27,954,000 | 30,700,000 | 30,166,000 | 30,129,000 | 29,774,000 |
S&GA Expenses | -10.6% | 19,815,000 | 22,175,000 | 21,429,000 | 20,838,000 | 21,618,000 | 19,879,000 | 19,792,000 | 19,669,000 | 20,888,000 | 17,734,500 | 18,370,000 | 19,250,000 | 17,973,000 | 19,805,000 | 17,726,000 | 14,290,000 | 17,838,000 | 18,804,000 | 18,245,000 | 18,467,000 | 16,434,000 |
R&D Expenses | 1.5% | 7,409,000 | 7,301,500 | 6,989,000 | 7,363,000 | 6,679,000 | 6,811,000 | 7,050,000 | 7,022,000 | 6,275,000 | 6,302,000 | 6,404,000 | 5,723,000 | 5,748,000 | 4,931,000 | 4,230,000 | 4,071,000 | 4,614,000 | 4,912,000 | 4,181,000 | 4,282,000 | 4,139,000 |
EBITDA Margin | 32.2% | -0.03 | -0.05 | -0.07 | -0.08 | -0.08 | -0.08 | -0.09 | -0.09 | -0.09 | -0.09 | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | -10.2% | 1,656,000 | 1,843,500 | 827,000 | 148,000 | 16,000 | -40,000 | 61,000 | 249,000 | 354,000 | -70,500 | 417,000 | 565,000 | 444,000 | 595,000 | 397,000 | 31,000 | 31,000 | 9,000 | 6,000 | 11,000 | 14,000 |
EBT Margin | 2.9% | -0.09 | -0.10 | -0.10 | -0.10 | -0.11 | -0.11 | -0.11 | -0.12 | -0.12 | -0.12 | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -70.4% | -6,635,000 | -3,893,000 | -4,089,000 | -6,660,000 | -7,074,000 | -5,415,000 | -4,318,000 | -7,740,000 | -11,475,000 | -5,286,000 | -7,141,000 | -7,898,000 | -6,660,000 | -6,010,000 | -1,479,000 | -8,105,000 | -8,192,000 | -7,038,000 | -5,571,000 | -7,022,000 | -9,504,000 |
Net Income Margin | 4.8% | -0.13 | -0.14 | -0.15 | -0.16 | -0.17 | -0.21 | -0.22 | -0.25 | -0.25 | -0.21 | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -687.9% | -13,190,000 | -1,674,000 | -2,064,000 | -4,123,000 | -11,727,000 | -5,260,000 | -5,059,000 | -9,737,000 | -16,088,000 | -8,684,000 | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -5.2% | 187 | 197 | 195 | 192 | 189 | 195 | 196 | 196 | 198 | 208 | 210 | 211 | 197 | 201 | 194 | 170 | 145 | 155 | 154 | 157 | 160 |
Current Assets | -10.6% | 79.00 | 88.00 | 87.00 | 86.00 | 89.00 | 98.00 | 102 | 107 | 112 | 127 | 135 | 142 | 135 | 145 | 140 | 140 | 120 | 135 | 137 | 141 | 146 |
Cash Equivalents | -30.0% | 22.00 | 31.00 | 31.00 | 23.00 | 8.00 | 15.00 | 21.00 | 18.00 | 21.00 | 39.00 | 53.00 | 59.00 | 46.00 | 56.00 | 68.00 | 86.00 | 42.00 | 42.00 | 31.00 | 31.00 | 30.00 |
Inventory | 20.1% | 28.00 | 23.00 | 23.00 | 21.00 | 20.00 | 19.00 | 19.00 | 19.00 | 17.00 | 17.00 | 15.00 | 13.00 | 13.00 | 13.00 | 12.00 | 13.00 | 15.00 | 14.00 | 14.00 | 14.00 | 13.00 |
Net PPE | - | - | - | - | - | - | - | - | - | - | 63.00 | 56.00 | 51.00 | 44.00 | 38.00 | 36.00 | 25.00 | 20.00 | 15.00 | 12.00 | 10.00 | 9.00 |
Liabilities | -7.7% | 93.00 | 101 | 97.00 | 94.00 | 92.00 | 94.00 | 94.00 | 94.00 | 94.00 | 95.00 | 95.00 | 92.00 | 78.00 | 78.00 | 72.00 | 50.00 | 21.00 | 22.00 | 19.00 | 19.00 | 20.00 |
Current Liabilities | -24.6% | 23.00 | 30.00 | 27.00 | 24.00 | 21.00 | 24.00 | 24.00 | 24.00 | 23.00 | 24.00 | 23.00 | 22.00 | 22.00 | 23.00 | 19.00 | 14.00 | 19.00 | 21.00 | 17.00 | 16.00 | 16.00 |
Long Term Debt | 0.5% | 47.00 | 47.00 | 46.00 | 46.00 | 46.00 | 46.00 | 45.00 | 45.00 | 45.00 | 45.00 | 46.00 | 46.00 | 32.00 | 32.00 | 32.00 | 32.00 | 1.00 | - | 2.00 | 2.00 | 3.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 |
LT Debt, Non Current | -100.0% | - | 47.00 | 46.00 | 46.00 | 46.00 | 46.00 | 45.00 | 45.00 | 45.00 | 45.00 | 46.00 | 46.00 | 32.00 | 32.00 | 19.00 | - | 1.00 | - | 2.00 | 2.00 | 3.00 |
Shareholder's Equity | -2.6% | 93.00 | 96.00 | 98.00 | 97.00 | 98.00 | 101 | 101 | 102 | 104 | 113 | 115 | 119 | 120 | 123 | 122 | 120 | 124 | 132 | 135 | 138 | 141 |
Retained Earnings | -2.4% | -287 | -281 | -277 | -273 | -266 | -259 | -254 | -249 | -242 | -230 | -225 | -218 | -210 | -203 | -197 | -196 | -188 | -179 | -172 | -167 | -160 |
Additional Paid-In Capital | 1.1% | 381 | 377 | 375 | 370 | 364 | 360 | 355 | 351 | 346 | 343 | 340 | 336 | 330 | 326 | 319 | 316 | 312 | 312 | 308 | 305 | 301 |
Shares Outstanding | 1.3% | 44.00 | 43.00 | 43.00 | 43.00 | 43.00 | 42.00 | 42.00 | 42.00 | 42.00 | 41.00 | 41.00 | 41.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 314 | - | - | - | 222 | - | - | - | 642 | - | - | - | 217 | - | - | - | 540 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -5713.3% | -12,266 | -211 | 1,626 | 292 | -7,423 | 1,362 | -689 | -5,688 | -11,051 | -1,514 | -376 | -695 | -10,820 | 2,837 | 2,618 | -7,029 | -8,052 | -3,330 | -1,864 | -5,811 | -8,867 |
Share Based Compensation | 195.3% | 3,919 | 1,327 | 4,747 | 5,390 | 2,954 | 4,154 | 3,849 | 4,910 | 2,678 | 1,509 | 2,911 | 3,805 | 2,694 | 2,745 | 2,947 | 2,222 | 556 | 2,920 | 2,395 | 2,674 | 2,315 |
Cashflow From Investing | -1073.6% | -3,251 | -277 | 5,994 | 14,322 | -786 | -1,209 | 2,971 | 2,279 | -7,241 | -13,585 | -6,777 | -4,157 | 870 | -19,352 | -21,130 | 14,969 | 8,550 | 13,586 | 921 | 4,994 | 7,770 |
Cashflow From Financing | -51.2% | 204 | 418 | 5.00 | 898 | 633 | 813 | 215 | 671 | 95.00 | 1,043 | 805 | 18,087 | 517 | 4,515 | 191 | 36,096 | -328 | 913 | 620 | 2,173 | 325 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.00 | 8.00 | 17.00 | 639 | - | - | - | - |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenues | $ 41,378 | $ 36,664 |
Cost of goods sold | 8,758 | 8,172 |
Gross profit | 32,620 | 28,492 |
Costs and expenses: | ||
Sales and marketing | 19,815 | 19,446 |
Research and development | 7,409 | 6,326 |
General and administrative | 9,956 | 10,061 |
Total costs and expenses | 37,180 | 35,833 |
Loss from operations | (4,560) | (7,341) |
Other income (expense): | ||
Investment income | 293 | 549 |
Interest expense | (2,326) | (16) |
Change in fair value of derivatives | 65 | (185) |
Other expense | (107) | (81) |
Total other (expense) income, net | (2,075) | 267 |
Net loss | $ (6,635) | $ (7,074) |
Weighted average common shares outstanding - basic (in shares) | 43,233,149 | 42,571,021 |
Weighted average common shares outstanding - diluted (in shares) | 43,233,149 | 42,571,021 |
Loss per common share - basic (in USD per share) | $ (0.15) | $ (0.17) |
Loss per common share - diluted (in USD per share) | $ (0.15) | $ (0.17) |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 15,713 | $ 31,024 |
Restricted cash | 6,000 | 6,002 |
Investments | 1,921 | 0 |
Accounts receivable, net of allowance for doubtful accounts of $603 and $337, respectively | 24,212 | 25,147 |
Inventory | 27,636 | 23,020 |
Prepaid expenses and other | 3,181 | 2,811 |
Total current assets | 78,663 | 88,004 |
Property and equipment, net | 87,838 | 88,730 |
Operating lease right-of-use assets | 15,247 | 15,562 |
Intangible assets, net | 4,768 | 4,531 |
Total assets | 186,516 | 196,827 |
Current liabilities: | ||
Accounts payable and accrued expenses | 21,288 | 28,883 |
Current maturities of long-term lease obligations | 1,644 | 1,547 |
Total current liabilities | 22,932 | 30,430 |
Long-term debt, net of debt discount and financing fees | 46,825 | 46,603 |
Long-term lease obligations | 20,681 | 21,142 |
Debt derivative liabilities | 2,922 | 2,987 |
Total liabilities | 93,360 | 101,162 |
Commitments and contingencies - see Note 12 | ||
Shareholders’ equity: | ||
Common stock, $0.01 par value per share; 100,000,000 shares authorized; 43,687,729 and 43,124,496 shares issued and outstanding | 437 | 431 |
Additional paid-in capital | 380,650 | 376,530 |
Accumulated deficit | (287,931) | (281,296) |
Total shareholders’ equity | 93,156 | 95,665 |
Total liabilities and shareholders’ equity | $ 186,516 | $ 196,827 |